AWS introduces P-EAGLE, an advancement in speculative decoding for large language model (LLM) inference. P-EAGLE generates all K draft tokens in a single forward pass, removing the sequential bottleneck inherent in traditional speculative decoding. In real workloads on NVIDIA B200, it delivers up to a 1.69x speedup versus vanilla EAGLE-3. Users unlock the improvement by enabling the parallel_drafting flag in the vLLM serving pipeline. Pre-trained P-EAGLE heads are already available on HuggingFace for GPT-OSS 120B, GPT-OSS 20B, and Qwen3-Coder 30B, enabling immediate experimentation. This release highlights a practical path to faster LLM inference across diverse models and deployments.

• Enable parallel drafting in vLLM by turning on parallel_drafting
• Achieve up to 1.69x speedup over EAGLE-3 on real workloads
• Use pre-trained P-EAGLE heads from HuggingFace for select models
• Deploy in real workloads to boost throughput and responsiveness
• Leverage readily available heads to start experimenting today

A clinical environment simulator is presented to enable dynamic evaluation of AI in medical settings. The article references studies on the influence of large language models on diagnostic reasoning and AI-assisted diagnosis. The simulator aims to quantify AI impact on diagnostic performance, clinical decision-making, and patient care tasks within realistic workflows. It supports randomized trials and simulated clinical scenarios to assess AI tools. The piece cites several works (e.g., JAMA Netw Open 2024; Nature Medicine 2025; JAMA Intern Med 2024; Nat Med 2025) to illustrate the growing evidence base for dynamic AI assessment in healthcare.

• Define dynamic evaluation scenarios for AI tools
• Benchmark diagnostic reasoning with randomized trials
• Integrate clinicians’ feedback into simulations
• Reference diverse studies to validate the approach

Analysts see meaningful upside in two AI-focused stocks, driven by AI initiatives across their platforms. Meta Platforms is leveraging AI to deepen user engagement and improve ad performance, with an ambitious vision for smart glasses. Atlassian’s software suite remains a developer-standard platform, and early signals suggest AI coding tools could raise developer output. Barton Crockett of Rosenblatt Securities treats Meta as undervalued, with a target price implying roughly 75% upside from a $653 share price. Keith Weiss of Morgan Stanley views Atlassian as undervalued at around $76 per share, with a target price noted though not fully disclosed in the excerpt. The piece frames these valuations as reflections of AI-driven growth potential and ongoing product innovations.

• Identify AI-driven growth catalysts for each company
• Cite analyst targets signaling upside potential
• Highlight AI initiatives tightening user engagement and developer productivity
• Note valuation gaps versus market expectations